Central Bank & Trust CO Emergent Bio Solutions Inc. Transaction History

Central Bank & Trust CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	SELL	$3.17 - $7.91 $396 - $988	-125 Reduced 20.13%	496 $1,000
Q2 2022 Jul 22, 2022	SELL	$27.42 - $43.63 $383 - $610	-14 Reduced 2.2%	621 $19,000
Q1 2022 Apr 18, 2022	SELL	$36.48 - $52.22 $14,300 - $20,470	-392 Reduced 38.17%	635 $26,000
Q4 2021 Jan 18, 2022	SELL	$33.11 - $55.01 $8,542 - $14,192	-258 Reduced 20.08%	1,027 $45,000
Q3 2021 Oct 19, 2021	SELL	$50.07 - $66.05 $605,596 - $798,874	-12,095 Reduced 90.4%	1,285 $64,000
Q2 2021 Jul 16, 2021	SELL	$56.61 - $80.46 $2.08 Million - $2.96 Million	-36,809 Reduced 73.34%	13,380 $843,000
Q1 2021 Apr 20, 2021	BUY	$86.23 - $125.19 $198,501 - $288,187	2,302 Added 4.81%	50,189 $4.66 Million
Q4 2020 Jan 12, 2021	SELL	$79.17 - $111.47 $8,550 - $12,038	-108 Reduced 0.23%	47,887 $4.29 Million
Q3 2020 Oct 08, 2020	BUY	$81.91 - $134.94 $160,953 - $265,157	1,965 Added 4.27%	47,995 $4.96 Million
Q2 2020 Jul 15, 2020	BUY	$54.33 - $89.52 $2.5 Million - $4.12 Million	46,030 New	46,030 $3.64 Million

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $504M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.